Watch the Replay: The Smallcap Revival Summits
Here is the latest financial fact sheet of DEEPAK NITRITE. For more details, see the DEEPAK NITRITE quarterly results and DEEPAK NITRITE share price and chart.
% ch | % | 1.1 |
No. of shares | m | 136.39 |
% ch week | % | -3.3 |
% ch 1-mth | % | 7.2 |
% ch 12-mth | % | 144.0 |
52 week H/L | Rs | 1,085.0/310.0 |
No. of Mths Year Ending |
12 Mar-15 |
12 Mar-16* |
12 Mar-17* |
12 Mar-18* |
12 Mar-19* |
5-Yr Chart Click to enlarge
|
---|
DEEPAK NITRITE EQUITY SHARE DATA | |||||||
---|---|---|---|---|---|---|---|
High | Rs | 975 | 80 | 134 | 299 | 305 | |
Low | Rs | 64 | 55 | 65 | 129 | 205 | |
Sales per share (Unadj.) | Rs | 127.0 | 114.9 | 104.9 | 121.1 | 198.0 | |
Earnings per share (Unadj.) | Rs | 5.1 | 5.6 | 7.4 | 5.8 | 12.7 | |
Diluted earnings per share | Rs | 3.9 | 4.8 | 7.1 | 5.8 | 12.7 | |
Cash flow per share (Unadj.) | Rs | 8.6 | 9.0 | 11.0 | 9.6 | 18.4 | |
Dividends per share (Unadj.) | Rs | 1.00 | 1.20 | 1.20 | 1.30 | 2.00 | |
Adj. dividends per share | Rs | 0.77 | 1.02 | 1.15 | 1.30 | 2.00 | |
Dividend yield (eoy) | % | 0.2 | 1.8 | 1.2 | 0.6 | 0.8 | |
Book value per share (Unadj.) | Rs | 33.2 | 42.3 | 54.7 | 67.6 | 78.6 | |
Adj. book value per share | Rs | 25.4 | 36.0 | 52.4 | 67.6 | 78.6 | |
Shares outstanding (eoy) | m | 104.54 | 116.29 | 130.71 | 136.39 | 136.39 | |
Bonus/Rights/Conversions | - | - | - | IS | - | ||
Price / Sales ratio | x | 4.1 | 0.6 | 1.0 | 1.8 | 1.3 | |
Avg P/E ratio | x | 101.6 | 12.0 | 13.5 | 36.9 | 20.0 | |
P/CF ratio (eoy) | x | 60.7 | 7.5 | 9.0 | 22.2 | 13.8 | |
Price / Book Value ratio | x | 15.7 | 1.6 | 1.8 | 3.2 | 3.2 | |
Dividend payout | % | 19.6 | 21.4 | 16.3 | 22.4 | 15.7 | |
Avg Mkt Cap | Rs m | 54,309 | 7,815 | 13,025 | 29,181 | 34,752 | |
No. of employees | `000 | 1.4 | 1.4 | 1.3 | 1.4 | 1.4 | |
Total wages/salary | Rs m | 1,001 | 1,161 | 1,222 | 1,362 | 1,798 | |
Avg. sales/employee | Rs Th | 9,479.7 | 9,506.9 | 10,407.8 | 11,863.9 | 19,823.2 | |
Avg. wages/employee | Rs Th | 715.0 | 826.2 | 927.9 | 978.1 | 1,319.9 | |
Avg. net profit/employee | Rs Th | 381.7 | 463.7 | 731.4 | 567.6 | 1,275.1 |
DEEPAK NITRITE INCOME DATA | |||||||
---|---|---|---|---|---|---|---|
Net Sales | Rs m | 13,272 | 13,357 | 13,707 | 16,515 | 26,999 | |
Other income | Rs m | 21 | 15 | 109 | 123 | 151 | |
Total revenues | Rs m | 13,292 | 13,373 | 13,816 | 16,638 | 27,150 | |
Gross profit | Rs m | 1,397 | 1,683 | 1,353 | 1,963 | 4,139 | |
Depreciation | Rs m | 360 | 395 | 480 | 526 | 778 | |
Interest | Rs m | 380 | 391 | 341 | 452 | 833 | |
Profit before tax | Rs m | 677 | 913 | 641 | 1,109 | 2,680 | |
Minority Interest | Rs m | 0 | 0 | 0 | 0 | 0 | |
Prior Period Items | Rs m | 0 | 0 | 0 | 0 | 0 | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | 705 | 0 | 0 | |
Tax | Rs m | 143 | 262 | 382 | 318 | 943 | |
Profit after tax | Rs m | 534 | 652 | 963 | 790 | 1,737 | |
Gross profit margin | % | 10.5 | 12.6 | 9.9 | 11.9 | 15.3 | |
Effective tax rate | % | 21.1 | 28.7 | 59.7 | 28.7 | 35.2 | |
Net profit margin | % | 4.0 | 4.9 | 7.0 | 4.8 | 6.4 |
DEEPAK NITRITE BALANCE SHEET DATA | |||||||
---|---|---|---|---|---|---|---|
Current assets | Rs m | 4,784 | 5,948 | 7,506 | 9,929 | 11,617 | |
Current liabilities | Rs m | 4,839 | 5,971 | 8,073 | 10,476 | 8,836 | |
Net working cap to sales | % | -0.4 | -0.2 | -4.1 | -3.3 | 10.3 | |
Current ratio | x | 1.0 | 1.0 | 0.9 | 0.9 | 1.3 | |
Inventory Days | Days | 29 | 37 | 45 | 72 | 56 | |
Debtors Days | Days | 86 | 85 | 96 | 91 | 78 | |
Net fixed assets | Rs m | 5,867 | 6,074 | 9,351 | 15,421 | 17,497 | |
Share capital | Rs m | 209 | 233 | 261 | 273 | 273 | |
"Free" reserves | Rs m | 3,259 | 4,681 | 6,887 | 8,949 | 10,443 | |
Net worth | Rs m | 3,468 | 4,913 | 7,149 | 9,221 | 10,716 | |
Long term debt | Rs m | 2,386 | 1,586 | 2,184 | 5,505 | 8,699 | |
Total assets | Rs m | 11,236 | 12,856 | 17,875 | 25,906 | 29,278 | |
Interest coverage | x | 2.8 | 3.3 | 2.9 | 3.5 | 4.2 | |
Debt to equity ratio | x | 0.7 | 0.3 | 0.3 | 0.6 | 0.8 | |
Sales to assets ratio | x | 1.2 | 1.0 | 0.8 | 0.6 | 0.9 | |
Return on assets | % | 8.1 | 8.1 | 7.3 | 4.8 | 8.8 | |
Return on equity | % | 15.4 | 13.3 | 13.5 | 8.6 | 16.2 | |
Return on capital | % | 18.1 | 20.1 | 18.1 | 10.6 | 18.1 | |
Exports to sales | % | 38.7 | 38.0 | 33.0 | 0 | 0 | |
Imports to sales | % | 19.8 | 16.8 | 12.7 | 0 | 0 | |
Exports (fob) | Rs m | 5,138 | 5,073 | 4,519 | 0 | 0 | |
Imports (cif) | Rs m | 2,621 | 2,248 | 1,739 | 0 | 0 | |
Fx inflow | Rs m | 5,138 | 5,073 | 4,637 | 5,090 | 5,791 | |
Fx outflow | Rs m | 2,845 | 2,496 | 1,957 | 2,237 | 3,181 | |
Net fx | Rs m | 2,292 | 2,578 | 2,680 | 2,853 | 2,610 |
DEEPAK NITRITE CASH FLOW | |||||||
---|---|---|---|---|---|---|---|
From Operations | Rs m | 1,052 | 1,912 | 490 | 1,830 | 637 | |
From Investments | Rs m | -866 | -1,622 | -3,526 | -5,247 | -1,626 | |
From Financial Activity | Rs m | -223 | -279 | 3,046 | 3,453 | 924 | |
Net Cashflow | Rs m | -37 | 11 | 11 | 36 | -65 |
Share Holding
|
Company Information
|
CHM: C. K. Mehta | COMP SEC: H. N. Shah (Chief-Law) | YEAR OF INC: 1970 | BSE CODE: 506401 | FV (Rs): 10 | DIV YIELD (%): 0.2 |
Read: DEEPAK NITRITE 2018-19 Annual Report Analysis
More Chemicals & Pesticides Company Fact Sheets: EXCEL CROP CARE BAYER CROPSCIENCE CLARIANT CHEMICALS NACL INDUSTRIES GUJARAT NARMADA
Compare DEEPAK NITRITE With: EXCEL CROP CARE BAYER CROPSCIENCE CLARIANT CHEMICALS NACL INDUSTRIES GUJARAT NARMADA
Extending losses to the fifth straight session, Indian share markets witnessed selling pressure throughout the day today and ended deep in the red.
For the quarter ended June 2020, DEEPAK NITRITE has posted a net profit of Rs 636 m (down 40.7% YoY). Sales on the other hand came in at Rs 4 bn (down 36.3% YoY). Read on for a complete analysis of DEEPAK NITRITE's quarterly results.
For the quarter ended March 2020, DEEPAK NITRITE has posted a net profit of Rs 1 bn (up 105.5% YoY). Sales on the other hand came in at Rs 5 bn (up 8.1% YoY). Read on for a complete analysis of DEEPAK NITRITE's quarterly results.
Here's an analysis of the annual report of DEEPAK NITRITE for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of DEEPAK NITRITE. Also includes updates on the valuation of DEEPAK NITRITE.
More Views on NewsIn this video, I'll show you why it might be the right time to take money of the table in pharma stocks.
The pandemic failed to thwart Richa's investing success formula for 2020.
In this video, I'll show you a crucial chart that you need to check before you decide to sell any stock or index.
Our ace stock picker is ready to capitalise on a big growth opportunity.
More